AI Article Synopsis
- A study was conducted on 31 Chinese children with childhood granulomatous periorificial dermatitis (CGPD) treated with oral roxithromycin.
- After 12 weeks, 90.3% of the patients showed full recovery, indicating a high success rate for the treatment.
- No severe adverse effects were reported, suggesting that oral roxithromycin is both effective and safe for treating CGPD.
Article Abstract
Data regarding the treatment of childhood granulomatous periorificial dermatitis (CGPD) using oral therapies are limited. This study included 31 Chinese children with CGPD treated with oral roxithromycin. After 12 weeks of treatment, 90.3% of the patients recovered, and there were no severe adverse effects. Our results suggest that oral roxithromycin is an effective and safe treatment for CGPD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/pde.15368 | DOI Listing |
Publication Analysis
Top Keywords
oral roxithromycin
12
childhood granulomatous
8
granulomatous periorificial
8
periorificial dermatitis
8
chinese children
8
treated oral
8
dermatitis chinese
4
children treated
4
oral
4
roxithromycin data
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!